Register      Login
Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
RESEARCH ARTICLE

An audit of pneumococcal and hepatitis vaccination in an outpatient HIV clinic

Michael G. Hunter A B C and Jeffrey J. Post A B
+ Author Affiliations
- Author Affiliations

A Albion Street Centre, Prince of Wales Hospital, Surry Hills, NSW 2010, Australia.

B Prince of Wales Clinical School, University of New South Wales, Randwick, NSW 2031, Australia.

C Corresponding author. Email: michaelgarvinhunter@hotmail.com

Sexual Health 9(5) 495-496 https://doi.org/10.1071/SH11192
Submitted: 29 December 2011  Accepted: 28 February 2012   Published: 10 August 2012

Abstract

Background: HIV-positive adults are at risk of vaccine preventable infections including Streptococcus pneumoniae, hepatitis A virus (HAV) and hepatitis B virus (HBV). Uptake of immunisations in HIV patients is suboptimal despite evidence of efficacy. Methods: An audit was made of the vaccination records in 200 adult HIV-positive regular clinic attendees, with a CD4+ count >200 cells μL–1. Results: Medical records or laboratory data revealed that 10% had been vaccinated against S. pneumoniae; 74% were immune or immunised against HAV; 40% had evidence of natural infection with HBV and 84% of nonimmune patients had been vaccinated. Conclusions: Strategies to improve vaccine uptake are required.


References

[1]  de Gaetano Donati K, Bertagnolio S, Tumbarello M, Tacconelli E, Cataldo M, Longo B, et al Effect of highly active antiretroviral therapy on the incidence of bacterial pneumonia in HIV-infected subjects. Int J Antimicrob Agents 2000; 16 357–60.
Effect of highly active antiretroviral therapy on the incidence of bacterial pneumonia in HIV-infected subjects.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD3cXot12ktLo%3D&md5=e1699c022640a465b878cacd39da2f0bCAS | 11091063PubMed |

[2]  Hirschtick RE, Glassroth J, Jordan MC, Wilcosky TC, Wallace JM, Kvale PA, et al Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary complications of HIV Infection Study Group. N Engl J Med 1995; 333 845–51.
Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary complications of HIV Infection Study Group.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK2MznvF2jtA%3D%3D&md5=6689361daf29f1251417a0e2f0542a5bCAS | 7651475PubMed |

[3]  Aspa J, Rajas O, Rodriguez de Castro F, Huertas MC, Borderias L, Cabello FJ, et al Impact of initial antibiotic choice on mortality from pneumococcal pneumonia. Eur Respir J 2006; 27 1010–9.
| 1:STN:280:DC%2BD283nsl2jtg%3D%3D&md5=7e6073c7c356b23b7da915e8a8cffd1cCAS | 16455824PubMed |

[4]  Breiman RF, Keller DW, Phelan MA, Sniadack DH, Stephens DS, Rimland D, et al Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients. Arch Intern Med 2000; 160 2633–8.
Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3cvosFWlsQ%3D%3D&md5=6649daea9882f0753578f2a2160e1f85CAS | 10999977PubMed |

[5]  Rodriguez-Barradas MC, Goulet J, Brown S, Goetz MB, Rimland D, Simberkoff MS, et al Impact of pneumococcal vaccination on the incidence of pneumonia by HIV infection status among patients enrolled in the Veterans Aging Cohort 5-Site Study. Clin Infect Dis 2008; 46 1093–100.
Impact of pneumococcal vaccination on the incidence of pneumonia by HIV infection status among patients enrolled in the Veterans Aging Cohort 5-Site Study.Crossref | GoogleScholarGoogle Scholar | 18444830PubMed |

[6]  Hadler SC, Judson FN, O’Malley PM, Altman NL, Penley K, Buchbinder S, et al Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. J Infect Dis 1991; 163 454–457.
Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK3M7ktVSjtA%3D%3D&md5=a6babdcbe73d9152d1f40c1f9f9d3dd8CAS | 1825315PubMed |

[7]  Thio CL. Hepatitis B and human immunodeficiency virus coinfection. Hepatology 2009; 49 S138–45.
Hepatitis B and human immunodeficiency virus coinfection.Crossref | GoogleScholarGoogle Scholar | 19399813PubMed |

[8]  Ferson MJ, Young LC, Stokes ML. Changing epidemiology of hepatitis A in the 1990s in Sydney, Australia. Epidemiol Infect 1998; 121 631–6.
Changing epidemiology of hepatitis A in the 1990s in Sydney, Australia.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK1M7ltlOrtg%3D%3D&md5=3c39a3c4b24f6ab4088dbaee1b780d99CAS | 10030713PubMed |

[9]  National Health and Medical Research Council (NHMRC) The Australian immunisation handbook, 9th edition. Canberra: Department of Health and Aging; 2008.

[10]  Molton J, Smith C, Chaytor S, Maple P, Brown K, Johnson M, et al Seroprevalence of common vaccine-preventable viral infections in HIV-positive adults. J Infect 2010; 61 73–80.
Seroprevalence of common vaccine-preventable viral infections in HIV-positive adults.Crossref | GoogleScholarGoogle Scholar | 20403382PubMed |

[11]  Stone EG, Morton SC, Hulscher ME, Maglione MA, Roth EA, Grimshaw JM, et al Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med 2002; 136 641–51.
| 11992299PubMed |